Biopsy specimen microvessel density is a useful prognostic marker in patients with T2-4M0 esophageal cancer treated with chemoradiotherapy

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 124-130

  Hironaka, Shuichi ^a,b   Hasebe, Takahiro ^a   Kamijo, Tomoyuki ^a   Ohtsu, Atsushi ^a,b   Ochiai, Atsushi ^a   Boku, Narikazu ^b   Yoshida, Shigeaki ^b   Saitoh, Hiroki ^c  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLIN D1; DIHYDROPYRIMIDINE DEHYDROGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; GLUTATHIONE TRANSFERASE; KI 67 ANTIGEN; PROTEIN P53; THYMIDYLATE SYNTHASE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL CHEMISTRY; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD31; CISPLATIN; COMBINED MODALITY THERAPY; CYCLIN D1; DIHYDROURACIL DEHYDROGENASE (NADP); ENDOTHELIAL GROWTH FACTORS; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; KI-67 ANTIGEN; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; OXIDOREDUCTASES; RADIATION DOSAGE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036157425     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Combined modality infusional chemotherapy with radiation
2. A review of interactions between platinum coordination complexes and ionizing radiation: Implication for cancer therapy
3. Biological basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
4. Chemoradiation as primary management of esophageal cancer
5. Preoperative chemoradiation followed by trans-hiatal esophagectomy for carcinoma of the esophagus: Final report
6. Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus
7. 1 lymph node squamous cell carcinoma of the esophagus
8. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?
9. p53 function and dysfunction
10. Participation of p53 protein in the cellular response to DNA damage
11. Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immunohistochemical study
12. Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer
13. Hyperbaric oxygen and radiotherapy of a fibrosarcoma and of a squamous-cell carcinoma of C3H mice
14. Thymidylate synthase and drug resistance
15. Dihydropyrimidine dehydrogenase: A tumoral target for fluorouracil modulation
16. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II)
17. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy
18. Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma
19. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer
20. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy
21. Cyclin Dis a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma
22. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett’s esophagus associated adenocarcinoma and squamous cell carcinoma
23. Complete regression of recurrent esophageal carcinoma with reduced expression of glutathione S-transferase-π by treatment with continuous infusion of 5-fluorouracil and low-dose cisplatin infusion
24. Prognosis in esophageal carcinoma with cervical lymph node metastases
25. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cisplatinum
26. Clinical implications of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1)
27. 2 stage laryngeal squamous cell carcinoma treated with radiotherapy
28. Tumor hypoxia: Its impact on cancer therapy
29. Hypoxic fractions of human tumors xenografted into mice: A review
30. Tumor vascularity as a prognostic factor in cancer
31. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma
32. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus
33. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus
34. Predictive assays
35. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
36. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
37. Surgical therapy of oesophageal carcinoma